Twin-to-Twin Transfusion Syndrome (TTTS): Diagnosis, Staging & Treatment

TTTS affects 10–15% of monochorionic-diamniotic (MCDA) twin pregnancies. Unbalanced anastomoses cause net blood transfer from donor → recipient.

Pathophysiology

  • Donor: Hypovolemia → oliguria → oligohydramnios, growth restriction, anemia.
  • Recipient: Hypervolemia → polyuria → polyhydramnios, polycythemia, cardiac strain → hydrops.

Quintero Staging (I–V)

  • I: Discordant fluid only.
  • II: Donor bladder not visible.
  • III: Abnormal Dopplers (absent/reversed end-diastolic velocity in UA, reversed DV flow, pulsatile UV).
  • IV: Recipient hydrops.
  • V: Demise of one/both twins.

Treatment

  • Stage I: Surveillance (some regress).
  • Stage II–IV: Fetoscopic laser photocoagulation of communicating vessels (Solomon or selective technique) — gold standard. Survival: 70–85% ≥1 twin; 50–60% dual.
  • Amnioreduction: Palliation for early GA (<16w) or if laser unavailable; serial reductions.
  • Selective reduction: Radiofrequency ablation/cord coagulation if severe discordance/anomaly.
  • Delivery: If ≥28–30w with severe disease.

Monitoring

  • Weekly ultrasound from 16w in MCDA twins (fluid, bladders, Dopplers, growth).
  • Post-laser surveillance for TAPS, recurrence.

Early referral to fetal therapy center optimizes outcomes.

Infertility - Related Articles